相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical association of CXCR4 in primary tumor of papillary thyroid cancer and response to iodine-131 treatment
Korrakode Sirakriengkrai et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Reassessment of SST4 Somatostatin Receptor Expression Using SST4-eGFP Knockin Mice and the Novel Rabbit Monoclonal Anti-Human SST4 Antibody 7H49L61
Amelie Lupp et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Thyroid cancer incidence trends by histology in 25 countries: a population-based study
Adalberto Miranda-Filho et al.
LANCET DIABETES & ENDOCRINOLOGY (2021)
Current Guidelines for Management of Medullary Thyroid Carcinoma
Mijin Kim et al.
ENDOCRINOLOGY AND METABOLISM (2021)
Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019
Anastasios Maniakas et al.
JAMA ONCOLOGY (2020)
Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies
Christoph Werner et al.
TRANSLATIONAL ONCOLOGY (2020)
The Current Histologic Classification of Thyroid Cancer
Sylvia L. Asa
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2019)
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls
Carolien M. Beukhof et al.
BMC CANCER (2019)
Immunohistochemical Expression of Somatostatin Receptor Subtypes in a Panel of Neuroendocrine Neoplasias
Satu M. Remes et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2019)
Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours
Ylberta Kajtazi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Filetti et al.
ANNALS OF ONCOLOGY (2019)
Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers
Danilea M. Carmona Matos et al.
SURGERY (2019)
The roles and role-players in thyroid cancer angiogenesis
Sadegh Rajabi et al.
ENDOCRINE JOURNAL (2019)
Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin
Rebekka Mai et al.
SCIENTIFIC REPORTS (2019)
Differential somatostatin, CXCR4 chemokine and endothelin A receptor expression in WHO grade I-IV astrocytic brain tumors
Franziska Lange et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
Thomas Artur Werner et al.
JOURNAL OF CANCER (2018)
Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer
Claudia Stumpf et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival
Lisa H. de Vries et al.
ENDOCRINE (2018)
Upregulation of RAD51 expression is associated with progression of thyroid carcinoma
R. Sarwar et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2017)
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases
Deng-hua Pan et al.
ONCOTARGETS AND THERAPY (2017)
Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas
Daniel Kaemmerer et al.
ONCOTARGET (2017)
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets
Daniel Kaemmerer et al.
BMC CANCER (2017)
CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
Thomas A. Werner et al.
BRITISH JOURNAL OF CANCER (2017)
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma
Daniel Barretto Kendler et al.
ENDOCRINE (2017)
Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis
Merima Herac et al.
APMIS (2016)
Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
Xiaoli Zhu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin
Susann Stollberg et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Treatment and Prognosis of Anaplastic Thyroid Carcinoma: A Clinical Study of 50 Cases
Tian-Run Liu et al.
PLOS ONE (2016)
Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues
Ali Salavati et al.
SEMINARS IN NUCLEAR MEDICINE (2016)
Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer?
Fernanda Vaisman et al.
CLINICAL NUCLEAR MEDICINE (2015)
Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms
Daniel Kaemmerer et al.
ONCOTARGET (2015)
Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy
Daniel Kaemmerer et al.
ONCOTARGET (2015)
CXCR4 over-expression and survival in cancer: A system review and meta-analysis
Hongli Zhao et al.
ONCOTARGET (2015)
Tumor-Associated Macrophages in Glioblastoma Multiforme-A Suitable Target for Somatostatin Receptor-Based Imaging and Therapy?
Constantin Lapa et al.
PLOS ONE (2015)
Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
Laura Chinezu et al.
HUMAN PATHOLOGY (2014)
Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies
S. Woelfl et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2014)
Optimal Reference Genes for Normalization of qRT-PCR Data from Archival Formalin-fixed, Paraffin-embedded Breast Tumors Controlling for Tumor Cell Content and Decay of mRNA
Trine Tramm et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2013)
Reevaluation of sst1 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-7
Amelie Lupp et al.
REGULATORY PEPTIDES (2013)
Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies
Chiara Lambertini et al.
REGULATORY PEPTIDES (2013)
Somatostatin Receptor Subtype 2A Immunohistochemistry Using a New Monoclonal Antibody Selects Tumors Suitable for In Vivo Somatostatin Receptor Targeting
Meike Koerner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Expression of the proliferation marker Ki-67 associates with tumour staging and clinical outcome in differentiated thyroid carcinomas
Karsten Muessig et al.
CLINICAL ENDOCRINOLOGY (2012)
Somatostatin receptor expression in non-medullary thyroid carcinomas
Kalliopi Pazaitou-Panayiotou et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2012)
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas
Liborio Torregrossa et al.
MODERN PATHOLOGY (2012)
Reassessment of sst(3) Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5
Amelie Lupp et al.
NEUROENDOCRINOLOGY (2012)
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study
George Pentheroudakis et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Reassessment of sst(5) Somatostatin Receptor Expression in Normal and Neoplastic Human Tissues Using the Novel Rabbit Monoclonal Antibody UMB-4
Amelie Lupp et al.
NEUROENDOCRINOLOGY (2011)
Prognostic Value of Histological and Immunohistochemical Characteristics for Predicting the Recurrence of Medullary Thyroid Carcinoma
A. Rios et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Somatostatin Receptor Subtype Expression in Human Thyroid Tumours
A. Klagge et al.
HORMONE AND METABOLIC RESEARCH (2010)
Vascular CXCR4 Expression - a Novel Antiangiogenic Target in Gastric Cancer?
Barbara Ingold et al.
PLOS ONE (2010)
Immunohistochemical expression of CXCR4 in thyroid carcinomas and thyroid benign lesions
Xin He et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Altered Chemokine Receptor Expression in Papillary Thyroid Cancer
Hernan E. Gonzalez et al.
THYROID (2009)
The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma
Patrick L. Wagner et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis
Hironao Yasuoka et al.
BMC CANCER (2008)
Reassessment of sst2 Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-1
Thomas Fischer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2
Thomas Fischer et al.
PLOS ONE (2008)
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer
Valentina De Falco et al.
CANCER RESEARCH (2007)
Evidence for Somatostatin receptor 2 in thyroid tissue
M. Druckenthaner et al.
REGULATORY PEPTIDES (2007)
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs
JJM Teunissen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Somatostatin receptors: from basic science to clinical approach-thyroid
MC Zatelli et al.
DIGESTIVE AND LIVER DISEASE (2004)
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas
MD Castellone et al.
ONCOGENE (2004)
Somatostatin analogues have no role in the treatment of advanced differentiated thyroid cancer
O Alhamarneh et al.
JOURNAL OF LARYNGOLOGY AND OTOLOGY (2004)
Differential expression of sst(1), sst(2A), and sst(3) somatostatin receptor proteins in low-grade and high-grade astrocytomas
C Mawrin et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
M Papotti et al.
CLINICAL ENDOCRINOLOGY (2001)
分享论文
